Clinical trials of Allergan’s antidepressant rapastinel fail

An analyst said the news could negatively affect shares of a successor to the company that developed rapastinel – which Allergan bought in 2015 – given that its drugs belong to the same class.
Source: https://ift.tt/2XLw4eh
0 Comments